Topic Briefing

Healthcare Policy

Executive Summary

This week's healthcare developments are headlined by a major FDA policy shift accepting de-identified Real-World Evidence for product reviews and CMS's move to restrict hospital-based gender-affirming care via Conditions of Participation. Simultaneously, clinical AI platforms are demonstrating significant financial returns in Medicare Shared Savings Program performance.

Key Takeaways

  • Hospitals face immediate financial risk: CMS proposed rules would use Conditions of Participation to cut all federal funding for Medicare and Medicaid-enrolled hospitals that provide gender-affirming care to minors. Source
  • Product review timelines accelerate: The FDA now accepts Real-World Evidence from macro-level databases without requiring individual patient data, removing a primary technical barrier for device and drug submissions. Source
  • Clinical AI demonstrates financial ROI: ACOs using AI-driven documentation and coordination tools achieved a 47% year-over-year increase in PMPM savings in the 2024 Medicare Shared Savings Program. Source
  • FDA seeks direct startup collaboration: A new RFI outlines a contracting model to bypass traditional systems integrators and work directly with venture-backed healthcare tech companies. Source

Key Themes

Major trends and developments identified from this week's coverage

Data Activation & Interoperability Enforcement

Federal agencies are moving toward API-centric interoperability while using the 'Information Blocking' rule to target automated systems and AI agents that restrict data flow.

3 articles

Federal Policy Realignment

New proposed rules shift federal oversight from patient safety standards to prohibiting specific clinical treatments, impacting 44% of total hospital spending.

3 articles

Key Players

Top companies, people, and technologies mentioned this week

Donald Trump
Person●●●●●

9 articles

Created by Genesis Mission, Created by NSPM-7

Microsoft
Company●●●●●

3 articles

Acquired by Anthropic, Collaborates with Anthropic

Google
Company●●●●●

2 articles

Acquired by Hume AI, Acquired by Intersect Power

Innovaccer Inc.
Company●●●●●

5 articles

Collaborates with American Medical Group Association (AMGA), Collaborates with Colorado Access

Epic
Company●●●●●

2 articles

Acquired by Health Gorilla, Acquired by State of Texas

KFF Health News
Company●●●●●

3 articles

Child of KFF, Collaborates with Johns Hopkins Bloomberg School of Public Health

Apple
Company●●●●●

2 articles

Acquired by Q.ai, Collaborates with Anthropic

Bruce Schneier
Person●●●●●

2 articles

Collaborates with Barath Raghavan, Collaborates with Ben Nassi

CMS
Company●●●●●

3 articles

Collaborates with Immigration and Customs Enforcement, Collaborates with Office of the National Coordinator for Health Information Technology

eSchool News
Company●●●●●

3 articles

Related to Digital Learning hub, Related to Educational Leadership hub

Regulatory & Policy Updates

Technology & Innovation

Launch of AI Agents for Chart Retrieval and HEDIS Coding

Automated coding tools are moving into risk adjustment workflows to reduce administrative overhead in CMS audits.

HTI-5 Rule Targets AI Agents for Information Blocking Enforcement

Health systems using automated scheduling or triage bots must ensure these tools do not inadvertently create data sharing barriers.

Clinical AI Facing Payer Reimbursement Battle in 2026

Adoption will rely on proving direct cost-savings as payers resist adding broad fee-for-service codes for AI-enabled diagnostics.

Market & Competitive Intelligence

Sanofi / Dynavax

M&A

Sanofi acquired Dynavax to expand its portfolio with a hepatitis B vaccine and shingles candidate.

AbbVie / Zejing Biopharmaceutical

Partnership

AbbVie signed a $100M upfront deal ($1.07B milestones) for a trispecific T-cell binder targeting small cell lung cancer.

Ultragenyx Pharmaceutical

Funding

Ultragenyx initiated major cost-cutting after two Phase 3 trials for its bone disease drug failed, causing shares to drop 43%.

Innovaccer / California DHCS

Partnership

California DHCS and CMS allocated $140M for a statewide partnership with Innovaccer to unify care for 2 million Medi-Cal patients.

What to Watch

Medicaid Eligibility Rollbacks (One Big Beautiful Bill Act)

Q1 2026 implementation expected

HHS plans significant budget reductions for Medicaid and SNAP, potentially stripping benefits from millions. Health plans are already scaling outreach to manage this churn.

Disability Rights & End-of-Life Policy Shifts

Ongoing 2026

Enforcement of accessibility standards for medical equipment and the legalization of medical aid in dying in 12 states will require operational adjustments for health systems.

Rare Pediatric Disease Incentive Program Replacement

Next legislative session

Following Senator Sanders' block of pediatric PRV reauthorization, drug developers must monitor for a replacement incentive program to support rare disease pipelines.

Editor's Picks

AI-recommended articles based on relevance and quality

Want personalized briefings?

Kelp creates AI-powered briefings tailored to your specific interests and sources. Get the insights that matter most to you.

Start Your Free Briefing